m6A Regulatory Gene-Mediated Methylation Modification in Glioma Survival Prediction

m6A Regulatory Gene-Mediated Methylation Modification in Glioma Survival Prediction

The median survival of patients with gliomas is relatively short. To investigate the epigenetic mechanisms associated with poor survival, we analyzed publicly available datasets from patients with glioma. This analysis revealed 12 prognosis-related m6A regulatory genes that may be responsible for po...

Full description

Bibliographic Details
Main Authors:	Guiyun Zhang, Ping Zheng, Yisong Lv, Zhonghua Shi, Fei Shi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Genetics
Subjects:	glioblastoma low grade glioma TCGA M6A immune infiltration
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.873764/full

Similar Items

Corrigendum: m6A regulatory gene-mediated methylation modification in glioma survival prediction
by: Guiyun Zhang, et al.
Published: (2022-12-01)

A dissected LMO2 functional analysis and clinical relevance in brain gliomas
by: Mei Yuan, et al.
Published: (2023-03-01)

Insights into the regulatory role of RNA methylation modifications in glioma
by: Shengrong Long, et al.
Published: (2023-11-01)

CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas
by: Bo Wang, et al.
Published: (2022-10-01)

Microbubble-Enhanced Focused Ultrasound for Infiltrating Gliomas
by: Alexandra A. Seas, et al.
Published: (2024-06-01)

Co‐amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma
by: Haiwei Wang, et al.
Published: (2023-02-01)

Gene discovery in glioma in the context of molecular reclassification of tumors
by: Khushboo Irshad, et al.
Published: (2015-12-01)

<it>MGMT </it>promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
by: Håvik Annette, et al.
Published: (2012-03-01)

Decoding the prognostic significance of integrator complex subunit 9 (INTS9) in glioma: links to TP53 mutations, E2F signaling, and inflammatory microenvironments
by: Yu-Chieh Lin, et al.
Published: (2023-08-01)

MicroRNAs in high-grade gliomas: What is their role?
by: Stepanović Aleksandar, et al.
Published: (2023-01-01)

Editorial: Surgical approaches for the treatment of glioma
by: G. La Rocca, et al.
Published: (2022-11-01)

A novel, effective machine learning-based RNA editing profile for predicting the prognosis of lower-grade gliomas
by: Boshen Wang, et al.
Published: (2023-07-01)

Primary Intramedullary Spinal High-Grade Glioma: A Case Series with Review of Literature
by: Aashita Aashita, et al.
Published: (2024-04-01)

RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma
by: Yimin Pan, et al.
Published: (2021-02-01)

m6A modification in RNA: biogenesis, functions and roles in gliomas
by: Yuhao Zhang, et al.
Published: (2020-09-01)

Comparative clinical and epidemiological study of central nervous system tumors in Pakistan and global database
by: Farheen Danish, et al.
Published: (2021-09-01)

DNA Methylation-Driven Genes for Developing Survival Nomogram for Low-Grade Glioma
by: Yingyun Guo, et al.
Published: (2022-01-01)

Integrating m6A Regulators-Mediated Methylation Modification Models and Tumor Immune Microenvironment Characterization in Caucasian and Chinese Low-Grade Gliomas
by: Wangrui Liu, et al.
Published: (2021-11-01)

Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment
by: Ruo-Lun Wei, et al.
Published: (2020-12-01)

Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas
by: Youjun Li, et al.
Published: (2023-05-01)

Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME)
by: Archya Dasgupta, et al.
Published: (2025-03-01)

Treatment Patterns and Outcomes of Patients with Grade 4 Glioma Treated with Radiation during the COVID-19 Pandemic
by: Manik Chahal, et al.
Published: (2023-03-01)

Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma
by: Peilin Cong, et al.
Published: (2021-09-01)

Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma Patients
by: Almuth F. Kessler, et al.
Published: (2020-07-01)

Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma
by: Shaojian Lin, et al.
Published: (2020-10-01)

Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations
by: Payal Aggarwal, et al.
Published: (2022-11-01)

Current FDA-Approved Therapies for High-Grade Malignant Gliomas
by: Jacob P. Fisher, et al.
Published: (2021-03-01)

Exploring the prognostic potential of m6A methylation regulators in low-grade glioma: implications for tumor microenvironment modulation
by: Honggang Wu, et al.
Published: (2024-01-01)

CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas
by: Liling Liu, et al.
Published: (2021-04-01)

The prognostic significance of androgen receptor expression in gliomas
by: Chi Zhang, et al.
Published: (2024-09-01)

The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers
by: Mario Mischkulnig, et al.
Published: (2022-09-01)

Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma
by: Vijay M. Patil, et al.
Published: (2020-07-01)

Review: therapeutic approaches for circadian modulation of the glioma microenvironment
by: Ella A. Nettnin, et al.
Published: (2023-12-01)

Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis
by: Chang Zeng, et al.
Published: (2023-08-01)

Prognostic value of four immune-related genes in lower-grade gliomas: a biomarker discovery study
by: Shuowen Wang, et al.
Published: (2024-08-01)

Brain Tsunamis in Human High-Grade Glioma: Preliminary Observations
by: Kayli Colpitts, et al.
Published: (2022-05-01)

Peroxidase is a novel potential marker in glioblastoma through bioinformatics method and experimental validation
by: Weiwei Shi, et al.
Published: (2022-08-01)

N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas
by: Feng Yuan, et al.
Published: (2022-09-01)

Angiogenic potential of the cerebrospinal fluid (CSF) of patients with high-grade gliomas measured with the chick embryo chorioallantoic membrane assay (CAM)
by: Mariana Sinning, et al.
Published: (2012-01-01)

DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma
by: Liu YJ, et al.
Published: (2022-03-01)